Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: Possible involvement of antioxidant and nitrergic pathways.
about
Profile of minocycline and its potential in the treatment of schizophreniaDrug models of schizophreniaDelayed emergence of behavioral and electrophysiological effects following juvenile ketamine exposure in miceThe benefit of minocycline on negative symptoms in early-phase psychosis in addition to standard care - extent and mechanism (BeneMin): study protocol for a randomised controlled trial.Brain in flames - animal models of psychosis: utility and limitationsGlutamate and dopamine in schizophrenia: an update for the 21st centurySystematic review and meta-analysis of the efficacy and safety of minocycline in schizophrenia.The inhibitory effect of minocycline on radiation-induced neuronal apoptosis via AMPKα1 signaling-mediated autophagy.Examining the potential preventative effects of minocycline prescribed for acne on the incidence of severe mental illnesses: A historical cohort study.Gender and estrous cycle influences on behavioral and neurochemical alterations in adult rats neonatally administered ketamine.Ketamine-induced behavioural and brain oxidative changes in mice: an assessment of possible beneficial effects of zinc as mono- or adjunct therapy.Antidepressant, antioxidant and neurotrophic properties of the standardized extract of Cocos nucifera husk fiber in mice.Average spectral power changes at the hippocampal electroencephalogram in schizophrenia model induced by ketamine.Neuroprotective effects of the ethanol stem bark extracts of Terminalia ivorensis in ketamine-induced schizophrenia-like behaviors and oxidative damage in mice.Nicorandil reverses the behavioral changes and brain oxidative stress in a model of schizophrenia induced by ketamine in mice
P2860
Q26864400-1670D3FD-F2D7-4AEE-B090-B161E450504EQ28084198-365A2496-179C-464A-B35B-878CA544ABB1Q30823871-3A19F910-9B28-4468-BF70-64C05467A796Q35154166-099CA4E8-15BD-4D03-A02D-29515D9FDC85Q35683865-4B4D17D7-C6FE-4107-98FE-50897BCF61FDQ36992322-2053D11A-CCC2-499C-8774-E402EB556657Q38970065-0F277C51-CE78-4366-8E76-169C38F00BD7Q47147793-41046A65-5ADF-4CE7-AB09-FFB5464C658CQ47352196-2CE245F4-5869-48B4-8608-3D3DC849D649Q47670264-2C3F28B7-1107-4C13-B56E-E08A5497B309Q47824089-B5E05290-362D-4B8C-A520-88712FD5A72EQ48064443-F3C231BC-D92A-45AA-A5DC-9BA6C99FDD39Q48156658-F474DA34-0507-4947-975D-292291A84D05Q48702321-FEBBEDBF-DF98-49A9-BAEA-E083D915C715Q57729831-CA9CFCC6-CD40-4DEE-B688-1BAC8DAE6D9E
P2860
Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: Possible involvement of antioxidant and nitrergic pathways.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Prevention and reversal of ket ...... xidant and nitrergic pathways.
@en
Prevention and reversal of ket ...... xidant and nitrergic pathways.
@nl
type
label
Prevention and reversal of ket ...... xidant and nitrergic pathways.
@en
Prevention and reversal of ket ...... xidant and nitrergic pathways.
@nl
prefLabel
Prevention and reversal of ket ...... xidant and nitrergic pathways.
@en
Prevention and reversal of ket ...... xidant and nitrergic pathways.
@nl
P2093
P2860
P50
P356
P1476
Prevention and reversal of ket ...... xidant and nitrergic pathways.
@en
P2093
Aline Santos Monte
André Férrer Carvalho
Bruna Mara Machado Ribeiro
David Freitas de Lucena
Francisca Cléa Florenço de Sousa
Greicy Coelho de Souza
Júnia Vieira dos Santos
Rafaela Carneiro Cordeiro
Roger S McIntyre
P2860
P304
P356
10.1177/0269881113503506
P407
P577
2013-09-17T00:00:00Z